Tanu Singla

Tanu Singla

Active Director Director DIN 08774132
DIN 08774132 First appointment Mar 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 4 historical roles
Total affiliations 6 Since Mar 2013
Shareholding value •••• Premium profile

About Tanu Singla

Data last updated:

Tanu Singla is a Director at Orchid Pharma Limited (since 2020) and Company Secretary at Ivrcl Chengapalli Tollways Limited (since 2024). The companies operate in Pharma, Infrastructure and Utilities and Automotive. The 2 current companies with reported revenue have a combined latest revenue of ₹1,149 Cr; the largest is Orchid Pharma Limited at ₹949 Cr (FY 2025). Earlier, Tanu Singla was a Company Secretary at Hero Cycles Limited (2023–2024) and Company Secretary at Ats Infrabuild Private Limited (2018–2022) and 2 more.

DIN 08774132
Primary Designation Director
Industry Pharma
First Appointment 08 Mar 2013
Oldest Company Age 34 yrs
Largest company Orchid Pharma Limited · ₹949 Cr (FY 2025)
Combined revenue ₹1,149 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Orchid Pharma Limited L24222TN1992PLC022994
Director29 Jun 20201992₹949 Cr (FY 2025)Active
Ivrcl Chengapalli Tollways Limited U45203TG2010PLC066886
Company Secretary03 Jul 20242010₹199 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hero Cycles Limited U35911PB1966PLC002667
Company Secretary21 Mar 20231966₹1,841 Cr (FY 2024)Active
Ats Infrabuild Private Limited U45400DL2007PTC168922
Company Secretary04 May 20182007₹80.01 Cr (FY 2025)Under Cirp
Sulog Transshipment Services Limited U61200UP2011FLC089538
Company Secretary08 Mar 20132011₹3.6 Lakh (FY 2022)Amalgamated
Nobility Estates Private Limited U70100DL2014PTC262971
Company Secretary31 Mar 20152014₹1.71 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Orchid Pharma Limited
Ivrcl Chengapalli Tollways Limited
Hero Cycles Limited
Ats Infrabuild Private Limited
Premium access

Shareholding and investment profile for Tanu Singla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tanu Singla

Tanu Singla currently holds 2 directorships: Orchid Pharma Limited (Director, since 29 Jun 2020, revenue ₹949 Cr (FY 2025)); Ivrcl Chengapalli Tollways Limited (Company Secretary, since 03 Jul 2024, revenue ₹199 Cr (FY 2025)).

Tanu Singla was first appointed on 08 Mar 2013 as Company Secretary at Sulog Transshipment Services Limited. The most recent appointment on record is 03 Jul 2024 at Ivrcl Chengapalli Tollways Limited.

The 2 current companies of Tanu Singla that report revenue have a combined latest revenue of ₹1,149 Cr: Orchid Pharma Limited ₹949 Cr (FY 2025); Ivrcl Chengapalli Tollways Limited ₹199 Cr (FY 2025).

Tanu Singla held 4 earlier board appointments: Hero Cycles Limited (Company Secretary, 21 Mar 2023 to 16 Apr 2024); Ats Infrabuild Private Limited (Company Secretary, 04 May 2018 to 17 Feb 2022); Sulog Transshipment Services Limited (Company Secretary, 08 Mar 2013 to 30 Jun 2013); Nobility Estates Private Limited (Company Secretary, 31 Mar 2015 to 30 Apr 2018).

The current boards of Tanu Singla's companies include Arjun Dhanuka (Orchid Pharma Limited), Dharam Vir (Orchid Pharma Limited), Kapil Dayya (Orchid Pharma Limited), Manish Dhanuka (Orchid Pharma Limited), Manoj Kumar Goyal (Orchid Pharma Limited), Mridul Dhanuka (Orchid Pharma Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available